A national audit of SGLT2 use in England

Ejemplares similares

• Sodium-glucose co-transporter 2 (SGLT2) inhibitor: comparing trial data and real-world use
  por: McGovern, A, et al.
  Publicado: (2017)
• Sodium-glucose co-transporter-2 (SGLT2) inhibitors: comparing trial and real world use (study protocol)
  por: McGovern, A, et al.
  Publicado: (2017)
• Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)
  por: Shah, S, et al.
  Publicado: (2018)
• Measuring quality of healthcare outcomes in type 2 diabetes from routine data: a seven-nation survey conducted by the IMIA Primary Health Care Working Group
  por: Hinton, W, et al.
  Publicado: (2017)
• Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis
  por: Whyte, M, et al.
  Publicado: (2019)